Advancements in AI systems for enhanced AI capabilities, dearth of skilled workforce, and increase in applications of innovative screening methods drive the growth of the market. However, limitations related to decision making and low acceptance rate due to risk of misinterpretation and injuries hamper the market growth. On the other hand, technological advancements and untapped potential in developing economies would create new opportunities for the market.

Software segment to maintain its lion's share throughout the forecast period

Software segment contributed nearly two-thirds of the total market share in 2017 and is expected to maintain its lion's share throughout the forecast period. This is due to its ability to offer early diagnosis and facilitate accurate & quality treatment. However, the hardware segment would register the fastest CAGR of 49.7% from 2018 to 2023, owing to the launch of innovative advanced hardware systems that offer improved efficiency. The services segment would witness steady growth during the forecast period.

Natural language processing segment to remain dominantthrough 2025

Natural language processing segment accounted for nearly half of the total market share in 2017, owing to improvements in interaction between human and machines using AI applications. This segment would continue its dominance through 2025. However, the deep learning segment would grow at the highest CAGR of 52.0% from 2018 to 2023, owing to the rise in awareness about this technology in the healthcare sector. The report also analyzes the querying method and context aware processing segments.

Robot assisted surgery segment to lead in terms of revenue by 2025

Robot assisted surgery segment contributed more than one-fourth of the total share in terms of revenue in 2017, and would continue to retain its lion's share through 2025. This is due to the improved precision of this technology to perform complex surgeries. However, the dosage error reduction segment would experience the highest CAGR of 50.3% from 2018 to 2023, owing to the warnings issued regarding calculation errors, incorrect medication orders, or mis-programming to prevent under- or over-delivery of a drug, electrolyte, or other fluids. The report also analyzes various applications such as virtual nursing assistant, administrative workflow assistance, fraud detection, clinical trial participant identifier, preliminary diagnosis, and others.

For Purchase Enquiry:https://www.alliedmarketresearch.com/purchase-enquiry/2421

Healthcare providers segment to remain dominant by 2025

Healthcare providers segment held a major share in 2017, contributing more than half of the total market revenue, owing to the rise in demand for information accuracy for patient safety, improvement in clinical outcomes, increase in aid reforms, and efforts to curb expenditure. This segment would remain dominant through 2025. However, the pharmaceuticals & biotechnology companies segment would register the highest CAGR of 49.7% from 2018 to 2023, owing to rise in the success rate of clinical trials and reduction in trial costs. The research also analyzes other end users, including patients and payers.

North America to lead in terms of revenue by 2025

North America contributed nearly half of the total market share in 2017, owing to rise in adoption of AI technology, increased collaborations among market players, and surge in R&D activities. This region will continue to lead during the forecast period. However, Asia-Pacific region would grow at the fastest CAGR of 53.4% from 2018 to 2025, owing to the limited availability of skilled professionals in rural regions and heavy inflow of investments for advancement of AI technology.

Frontrunners in the industry

The leading market players analyzed in the research include Welltok, Inc., Nvidia Corporation, Intel Corporation, IBM Corporation, Google Inc., General Vision, Inc., Microsoft Corporation, Next IT Corporation, Enlitic, Inc., and iCarbonX. Various strategies including joint ventures, collaborations, expansions, partnerships, mergers & acquisitions, and others have been adopted by the market players to gain a strong position in the industry.

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer